RESUMEN
During mitotic exit, missegregated chromosomes can recruit their own nuclear envelope (NE) to form micronuclei (MN). MN have reduced functioning compared to primary nuclei in the same cell, although the two compartments appear to be structurally comparable. Here we show that over 60% of MN undergo an irreversible loss of compartmentalization during interphase due to NE collapse. This disruption of the MN, which is induced by defects in nuclear lamina assembly, drastically reduces nuclear functions and can trigger massive DNA damage. MN disruption is associated with chromatin compaction and invasion of endoplasmic reticulum (ER) tubules into the chromatin. We identified disrupted MN in both major subtypes of human non-small-cell lung cancer, suggesting that disrupted MN could be a useful objective biomarker for genomic instability in solid tumors. Our study shows that NE collapse is a key event underlying MN dysfunction and establishes a link between aberrant NE organization and aneuploidy.
Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/patología , Inestabilidad Genómica , Neoplasias Pulmonares/patología , Micronúcleos con Defecto Cromosómico , Membrana Nuclear/metabolismo , Carcinoma de Pulmón de Células no Pequeñas/genética , Línea Celular Tumoral , Núcleo Celular/metabolismo , Daño del ADN , Humanos , Interfase , Laminas/metabolismo , Neoplasias Pulmonares/genéticaRESUMEN
Robust quantification of vegetative biomass using satellite imagery using one or more forms of machine learning (ML) has hitherto been hindered by the extent and quality of training data. Here, we showcase how ML predictive demonstrably improves when additional training data is used. We collated field datasets of pasture biomass obtained via destructive sampling, 'C-Dax' reflective measurements and rising plate meters (RPM) from ten livestock farms across four States in Australia. Remotely sensed data from the Sentinel-2 constellation was used to retrieve aboveground biomass using a novel machine learning paradigm hereafter termed "SPECTRA-FOR" (Spectral Pasture Estimation using Combined Techniques of Random-forest Algorithm for Features Optimisation and Retrieval). Using this framework, we show that the low temporal resolution of Sentinel-2 in high latitude regions with persistent cloud cover leads to extensive gaps between cloud-free images, hindering model performance and, thus, contemporaneous ability to forecast real-time pasture biomass. By leveraging the spectral consistency between Sentinel-2 and Planet Lab SuperDove to overcome this limitation, we used ten spectral bands of Sentinel-2, four bands of Sentinel-2 as a proxy for pre-2022 SuperDove (referred to as synthetic SuperDove or SSD), and the actual SuperDove (ASD), given that SuperDove imagery has a higher resolution and more frequent passage compared with Sentinel-2. Using their respective bands as input features to SPECRA-FOR, model performance for the ten bands of Sentinel-2 were R2 = 0.87, root mean squared error (RMSE) of 439 kg DM/ha and mean absolute error (MAE) of 255 kg DM/ha, while that for SSD increased to an R2 of 0.92, RMSE of 346 kg DM/ha and MAE = 208 kg DM/ha. The study revealed the importance of robust data mining, imagery harmonisation and model validation for accurate real-time modelling of pasture biomass with ML.
Asunto(s)
Aprendizaje Automático , Imágenes Satelitales , Imágenes Satelitales/métodos , Biomasa , Granjas , AustraliaRESUMEN
Low-grade fibromyxoid sarcoma (LGFMS) is a histopathologically deceptive soft tissue neoplasm with bland cytology, which is typically encountered in deep soft tissue of adults. We report two cases of superficial LGFMS in young patients (16 and 21 years old, respectively), which were difficult to diagnose on histopathologic and clinical findings alone. LGFMS commonly mimics benign neoplasms such as cellular neurothekeoma, fibromatosis, neurofibroma, and perineurioma. Malignancies included in the differential diagnosis are soft tissue neoplasms such as dermatofibrosarcoma protuberans and myxofibrosarcoma. A high degree of reported variation in pattern and cellularity among LGFMS further complicates the diagnosis. Careful examination and appropriate immunohistochemistry panels including MUC4 are essential for narrowing the differential diagnosis. Molecular studies for possible FUS translocation can confirm the diagnosis of LGFMS. Sufficient sampling and workup of these lesions are critical, especially in younger patients. Young age and superficial presentation can easily sway dermatopathologists/dermatologists toward an incorrect diagnosis of benignancy.
Asunto(s)
Fibroma , Fibrosarcoma , Neoplasias de la Vaina del Nervio , Neoplasias de los Tejidos Blandos , Adolescente , Adulto , Fibroma/diagnóstico , Fibroma/patología , Fibrosarcoma/diagnóstico , Fibrosarcoma/patología , Humanos , Inmunohistoquímica , Neoplasias de los Tejidos Blandos/patología , Adulto JovenRESUMEN
CONTEXT: Rapid on-site evaluation (ROSE) optimises the performance of cytology, but requires skilled handling, and smearing can make the material unavailable for some ancillary tests. There is a need to facilitate ROSE without sacrificing part of the sample. OBJECTIVE: We evaluated the image quality of inexpensive deconvolution fluorescence microscopy for optically sectioning non-smeared fine needle aspiration (FNA) tissue fragments. DESIGN: A portion of residual material from 14 FNA samples was stained for 3 min in Hoechst 33342 and Sypro™ Red to label DNA and protein respectively, transferred to an imaging chamber, and imaged at 200× or 400× magnification at 1 micron intervals using a GE DeltaVision inverted fluorescence microscope. A deconvolution algorithm was applied to remove out-of-plane signal, and the resulting images were inverted and pseudocoloured to resemble H&E sections. Five cytopathologists blindly diagnosed 2 to 4 representative image stacks per case (total 70 evaluations), and later compared them to conventional epifluorescent images. RESULTS: Accurate definitive diagnoses were rendered in 45 (64%) of 70 total evaluations; equivocal diagnoses (atypical or suspicious) were made in 21 (30%) of the 70. There were two false positive and two false negative "definite" diagnoses in three cases (4/70; 6%). Cytopathologists preferred deconvolved images compared to raw images (P < 0.01). The imaged fragments were recovered and prepared into a ThinPrep or cell block without discernible alteration. CONCLUSIONS: Deconvolution improves image quality of FNA fragments compared to epifluorescence, often allowing definitive diagnosis while enabling the ROSE material to be subsequently triaged.
Asunto(s)
Microscopía , Evaluación in Situ Rápida , Biopsia con Aguja Fina/métodos , Citodiagnóstico , Técnicas Citológicas , HumanosRESUMEN
The Shapiro xanthogranuloma is a histopathologic form of xanthogranuloma that shows closely packed monomorphous cells, which can extend into the subcutaneous fat; it usually lacks routine diagnostic features of xanthogranuloma. Herein we describe two cases of Shapiro xanthogranuloma occurring in a neonate and in an infant, which were initially thought to be hematologic malignancies. One patient's presentation as a "blueberry muffin baby" added to the diagnostic confusion. Pediatric dermatologists, dermatologists, and dermatopathologists need to be aware of the Shapiro xanthogranuloma and its clinicopathologic features to avoid misdiagnosis of a hematopoietic malignancy in neonates and infants.
Asunto(s)
Granuloma/diagnóstico , Neoplasias Hematológicas/diagnóstico , Leucemia/diagnóstico , Enfermedades de la Piel/patología , Xantogranuloma Juvenil/diagnóstico , Xantomatosis/diagnóstico , Concienciación , Dermatólogos , Errores Diagnósticos , Femenino , Granuloma/patología , Neoplasias Hematológicas/patología , Humanos , Lactante , Recién Nacido , Leucemia/patología , Masculino , Neurofibromatosis/complicaciones , Síndrome de Noonan/complicaciones , Patólogos , Xantogranuloma Juvenil/patología , Xantomatosis/patologíaRESUMEN
We describe a patient with leukemia undergoing chemotherapy who developed painful purpuric nodules of the digits. These findings were concerning for endocarditis (clinically) and angiokeratomas on gross histology. After extensive evaluation, we report the development of painful purpuric nodules as a likely side effect of the patient's therapeutic regimen (hydroxyurea, danorubicin, cytarabine, and methotrexate).
Asunto(s)
Angioqueratoma/inducido químicamente , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Dermatosis de la Mano/inducido químicamente , Leucemia/tratamiento farmacológico , Púrpura/inducido químicamente , Neoplasias Cutáneas/inducido químicamente , Angioqueratoma/diagnóstico , Citarabina/administración & dosificación , Daunorrubicina/administración & dosificación , Diagnóstico Diferencial , Femenino , Dermatosis de la Mano/diagnóstico , Humanos , Hidroxiurea/administración & dosificación , Metotrexato/administración & dosificación , Persona de Mediana Edad , Púrpura/diagnóstico , Púrpura/patología , Neoplasias Cutáneas/diagnósticoRESUMEN
Genetic lesions that activate KRAS account for â¼30% of the 1.6 million annual cases of lung cancer. Despite clinical need, KRAS is still undruggable using traditional small-molecule drugs/inhibitors. When oncogenic Kras is suppressed by RNA interference, tumors initially regress but eventually recur and proliferate despite suppression of Kras Here, we show that tumor cells can survive knockout of oncogenic Kras, indicating the existence of Kras-independent survival pathways. Thus, even if clinical KRAS inhibitors were available, resistance would remain an obstacle to treatment. Kras-independent cancer cells exhibit decreased colony formation in vitro but retain the ability to form tumors in mice. Comparing the transcriptomes of oncogenic Kras cells and Kras knockout cells, we identified 603 genes that were specifically up-regulated in Kras knockout cells, including the Fas gene, which encodes a cell surface death receptor involved in physiological regulation of apoptosis. Antibodies recognizing Fas receptor efficiently induced apoptosis of Kras knockout cells but not oncogenic Kras-expressing cells. Increased Fas expression in Kras knockout cells was attributed to decreased association of repressive epigenetic marks at the Fas promoter. Concordant with this observation, treating oncogenic Kras cells with histone deacetylase inhibitor and Fas-activating antibody efficiently induced apoptosis, thus bypassing the need to inhibit Kras. Our results suggest that activation of Fas could be exploited as an Achilles' heel in tumors initiated by oncogenic Kras.
Asunto(s)
Anticuerpos/farmacología , Carcinoma de Pulmón de Células no Pequeñas/genética , Neoplasias Pulmonares/genética , Proteínas Proto-Oncogénicas p21(ras)/genética , Receptor fas/genética , Animales , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Epigénesis Genética , Perfilación de la Expresión Génica , Regulación Neoplásica de la Expresión Génica , Técnicas de Inactivación de Genes , Humanos , Ratones , Mutación , Trasplante de Neoplasias , Regiones Promotoras Genéticas , Regulación hacia ArribaRESUMEN
BACKGROUND & AIMS: It has been a challenge to identify liver tumor suppressors or oncogenes due to the genetic heterogeneity of these tumors. We performed a genome-wide screen to identify suppressors of liver tumor formation in mice, using CRISPR-mediated genome editing. METHODS: We performed a genome-wide CRISPR/Cas9-based knockout screen of P53-null mouse embryonic liver progenitor cells that overexpressed MYC. We infected p53-/-;Myc;Cas9 hepatocytes with the mGeCKOa lentiviral library of 67,000 single-guide RNAs (sgRNAs), targeting 20,611 mouse genes, and transplanted the transduced cells subcutaneously into nude mice. Within 1 month, all the mice that received the sgRNA library developed subcutaneous tumors. We performed high-throughput sequencing of tumor DNA and identified sgRNAs increased at least 8-fold compared to the initial cell pool. To validate the top 10 candidate tumor suppressors from this screen, we collected data from patients with hepatocellular carcinoma (HCC) using the Cancer Genome Atlas and COSMIC databases. We used CRISPR to inactivate candidate tumor suppressor genes in p53-/-;Myc;Cas9 cells and transplanted them subcutaneously into nude mice; tumor formation was monitored and tumors were analyzed by histology and immunohistochemistry. Mice with liver-specific disruption of p53 were given hydrodynamic tail-vein injections of plasmids encoding Myc and sgRNA/Cas9 designed to disrupt candidate tumor suppressors; growth of tumors and metastases was monitored. We compared gene expression profiles of liver cells with vs without tumor suppressor gene disrupted by sgRNA/Cas9. Genes found to be up-regulated after tumor suppressor loss were examined in liver cancer cell lines; their expression was knocked down using small hairpin RNAs, and tumor growth was examined in nude mice. Effects of the MEK inhibitors AZD6244, U0126, and trametinib, or the multi-kinase inhibitor sorafenib, were examined in human and mouse HCC cell lines. RESULTS: We identified 4 candidate liver tumor suppressor genes not previously associated with liver cancer (Nf1, Plxnb1, Flrt2, and B9d1). CRISPR-mediated knockout of Nf1, a negative regulator of RAS, accelerated liver tumor formation in mice. Loss of Nf1 or activation of RAS up-regulated the liver progenitor cell markers HMGA2 and SOX9. RAS pathway inhibitors suppressed the activation of the Hmga2 and Sox9 genes that resulted from loss of Nf1 or oncogenic activation of RAS. Knockdown of HMGA2 delayed formation of xenograft tumors from cells that expressed oncogenic RAS. In human HCCs, low levels of NF1 messenger RNA or high levels of HMGA2 messenger RNA were associated with shorter patient survival time. Liver cancer cells with inactivation of Plxnb1, Flrt2, and B9d1 formed more tumors in mice and had increased levels of mitogen-activated protein kinase phosphorylation. CONCLUSIONS: Using a CRISPR-based strategy, we identified Nf1, Plxnb1, Flrt2, and B9d1 as suppressors of liver tumor formation. We validated the observation that RAS signaling, via mitogen-activated protein kinase, contributes to formation of liver tumors in mice. We associated decreased levels of NF1 and increased levels of its downstream protein HMGA2 with survival times of patients with HCC. Strategies to inhibit or reduce HMGA2 might be developed to treat patients with liver cancer.
Asunto(s)
Carcinoma Hepatocelular/genética , Regulación Neoplásica de la Expresión Génica , Hepatocitos/metabolismo , Neoplasias Hepáticas Experimentales/genética , Neoplasias Hepáticas/genética , Proteínas Quinasas Activadas por Mitógenos/genética , Proteínas Proto-Oncogénicas c-myc/genética , Proteína p53 Supresora de Tumor/genética , Animales , Bencimidazoles/farmacología , Western Blotting , Butadienos/farmacología , Sistemas CRISPR-Cas , Línea Celular Tumoral , Proteínas del Citoesqueleto , ADN de Neoplasias/genética , Inhibidores Enzimáticos , Genes de Neurofibromatosis 1 , Estudio de Asociación del Genoma Completo , Proteínas HMGA/genética , Proteína HMGA2/genética , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Inmunohistoquímica , Glicoproteínas de Membrana/genética , Ratones , Ratones Noqueados , Ratones Desnudos , Proteínas del Tejido Nervioso/genética , Niacinamida/análogos & derivados , Niacinamida/farmacología , Nitrilos/farmacología , Compuestos de Fenilurea/farmacología , Pronóstico , Inhibidores de Proteínas Quinasas/farmacología , Piridonas/farmacología , Pirimidinonas/farmacología , Reacción en Cadena en Tiempo Real de la Polimerasa , Receptores de Superficie Celular/genética , Análisis de Secuencia de ADN , Sorafenib , Análisis de Supervivencia , Proteínas Supresoras de Tumor/genética , Proteínas ras/genéticaAsunto(s)
Dermatitis , Liquen Plano , Humanos , Alopecia/etiología , Linfocitos , Factor de Transcripción STAT3RESUMEN
BACKGROUND: BAP-negative melanocytic tumors were unrecognized in the medical literature until 2011. While the clinical significance of these tumors is poorly understood, there is concern such lesions represent processes in transition, and malignant degeneration is a concern. We investigated use of a 23-gene expression profiling (23-GEP) test for distinction from melanoma with the aim of better characterizing the biologic potential of such tumors. METHODS: Twenty BAP-negative melanocytic tumors, subjected to 23-GEP (Myriad Genetic Laboratories, Inc. [Salt Lake City, Utah]) testing, were retrospectively analyzed. RESULTS: Tumors exhibited varying degrees of atypia and aberrant immunohistochemical profiles. 23-GEP testing revealed a "malignant" genetic signature in four cases, a "benign" signature in 15 cases, and an "indeterminate" signature in one case. Array-based comparative genomic hybridization (aCGH) testing was performed for two cases with a "malignant" 23-GEP signature, but the aCGH result conflicted with 23-GEP, and supported benignity. Conversely, in one case with a "benign" 23-GEP result, aCGH testing supported assessment as melanoma. Moreover, evolving melanoma could not be wholly excluded by histopathological analysis in 2 "benign" cases. CONCLUSIONS: BAP-negative melanocytic tumors remain a diagnostic dilemma for dermatopathologists. A widely marketed 23-GEP test may not be useful in distinguishing these tumors from spitzoid melanoma, at least in comparison to aCGH technology.
RESUMEN
Current debates about the role of external finance in development mostly overlook the insights from early development economics that late industrialisation generates a structural tendency to run trade deficits, thereby exacerbating rather than relieving external foreign exchange constraints. The developmental role of external finance is therefore based on its strategic marginal contribution to relieve such constraints. External debt in particular also allows countries to pursue industrial strategies without reliance on foreign direct investment. These insights are revisited in this paper as a critical input to both mainstream and heterodox contemporary scholarship on debt and development. While the mainstream generally avoids discussion of state-led industrial policy, the heterodox has converged on a view that developing countries should avoid external finance. The contrasting external account histories of South Korea and Brazil are examined to demonstrate the validity of the classic insights and the contemporary fallacies. While the South Korean case speaks much to its geopolitical context, this does not necessarily refute the principle that post-war late development engenders an intensive demand for external finance, which must be met if industrialisation strategies are not to be stymied, as in the case of Brazil, no matter how effectively domestic strategies are conceived and implemented.
Asunto(s)
Alopecia , Dermatitis , Alopecia/etiología , Alopecia/patología , Cicatriz/etiología , Cicatriz/patología , Dermatitis/patología , Cabello/patología , HumanosAsunto(s)
Mixoma/diagnóstico , Nevo/diagnóstico , Enfermedades de la Piel/patología , Neoplasias Cutáneas/patología , Adolescente , Antígenos CD34/metabolismo , Concienciación , Biopsia , Dermatólogos , Diagnóstico Diferencial , Errores Diagnósticos , Humanos , Masculino , Mucinosis Folicular/patología , Nevo/cirugía , Enfermedades de la Piel/congénitoAsunto(s)
Alcaptonuria/patología , Ocronosis/patología , Piel/patología , Femenino , Humanos , Persona de Mediana EdadAsunto(s)
Enfermedad de Crohn/complicaciones , Genitales/patología , Linfedema/patología , Piel/patología , Verrugas/patología , Administración Tópica , Adolescente , Antiinflamatorios/administración & dosificación , Antiinflamatorios/uso terapéutico , Biopsia/métodos , Quimioterapia Combinada , Femenino , Humanos , Inmunohistoquímica/métodos , Inmunosupresores/administración & dosificación , Inmunosupresores/uso terapéutico , Inyecciones Intralesiones , Linfedema/complicaciones , Dolor/diagnóstico , Dolor/etiología , Prurito/diagnóstico , Prurito/etiología , Sirolimus/administración & dosificación , Sirolimus/uso terapéutico , Piel/metabolismo , Resultado del Tratamiento , Triamcinolona/administración & dosificación , Triamcinolona/uso terapéuticoAsunto(s)
Alopecia/patología , Células Epiteliales/patología , Folículo Piloso/patología , Queratina-15/metabolismo , Células Madre/patología , Cicatriz/diagnóstico , Cicatriz/patología , Células Epiteliales/ultraestructura , Fibrosis/diagnóstico , Fibrosis/patología , Folículo Piloso/ultraestructura , Humanos , Liquen Plano/inmunología , Liquen Plano/patología , Lupus Eritematoso Discoide/inmunología , Lupus Eritematoso Discoide/patología , Microscopía Fluorescente/métodos , Células Madre/citología , Células Madre/inmunologíaRESUMEN
Ocean color remote sensing significantly contributes to our understanding of phytoplankton distribution and abundance and primary productivity in the Southern Ocean (SO). However, the current SO in situ optical database is still insufficient and unevenly distributed. This limits the ability to produce robust and accurate measurements of satellite-based chlorophyll. Based on data collected on cruises around the Antarctica Peninsula (AP) on January 2014 and 2016, this research intends to enhance our knowledge of SO water and atmospheric optical characteristics and address satellite algorithm deficiency of ocean color products. We collected high resolution in situ water leaving reflectance (±1 nm band resolution), simultaneous in situ chlorophyll-a concentrations and satellite (MODIS and VIIRS) water leaving reflectance. Field samples show that clouds have a great impact on the visible green bands and are difficult to detect because NASA protocols apply the NIR band as a cloud contamination threshold. When compared to global case I water, water around the AP has lower water leaving reflectance and a narrower blue-green band ratio, which explains chlorophyll-a underestimation in high chlorophyll-a regions and overestimation in low chlorophyll-a regions. VIIRS shows higher spatial coverage and detection accuracy than MODIS. After coefficient improvement, VIIRS is able to predict chlorophyll a with 53% accuracy.
Asunto(s)
Algoritmos , Clorofila/análisis , Fenómenos Ópticos , Tecnología de Sensores Remotos , Agua/química , Regiones Antárticas , Clorofila A , Simulación por Computador , Luz , Océanos y MaresRESUMEN
BACKGROUND: Whereas disease surveillance for infectious diseases such as rubella is important, it is critical to identify pregnant women at risk of passing rubella to their offspring, which can be fatal and can result in congenital rubella syndrome (CRS). The traditional centralized model for diagnosing rubella is cost-prohibitive in resource-limited settings, representing a major obstacle to the prevention of CRS. As a step toward decentralized diagnostic systems, we developed a proof-of-concept digital microfluidic (DMF) diagnostic platform that possesses the flexibility and performance of automated immunoassay platforms used in central facilities, but with a form factor the size of a shoebox. METHODS: DMF immunoassays were developed with integrated sample preparation for the detection of rubella virus (RV) IgG and IgM. The performance (sensitivity and specificity) of the assays was evaluated with serum and plasma samples from a commercial antirubella mixed-titer performance panel. RESULTS: The new platform performed the essential processing steps, including sample aliquoting for 4 parallel assays, sample dilution, and IgG blocking. Testing of performance panel samples yielded diagnostic sensitivity and specificity of 100% and 100% for both RV IgG and RV IgM. With 1.8 µL sample per assay, 4 parallel assays were performed in approximately 30 min with <10% mean CV. CONCLUSIONS: This proof of concept establishes DMF-powered immunoassays as being potentially useful for the diagnosis of infectious disease.
Asunto(s)
Anticuerpos Antivirales/sangre , Inmunoensayo/instrumentación , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Técnicas Analíticas Microfluídicas/instrumentación , Virus de la Rubéola/inmunología , Rubéola (Sarampión Alemán)/diagnóstico , Anticuerpos Antivirales/inmunología , Diseño de Equipo , Femenino , Humanos , Inmunoglobulina G/inmunología , Inmunoglobulina M/inmunología , Embarazo , Rubéola (Sarampión Alemán)/sangre , Rubéola (Sarampión Alemán)/inmunología , Virus de la Rubéola/aislamiento & purificación , Sensibilidad y EspecificidadRESUMEN
Melanoma is a tumor where virulence is conferred on transition from flat (radial) to three-dimensional (tumorigenic) growth. Virulence of tumorigenic growth is governed by numerous attributes, including presence of self-renewing stem-like cells and related formation of patterned networks associated with the melanoma mitogen, laminin, a phenomenon known as vasculogenic mimicry. Vasculogenic mimicry is posited to contribute to melanoma perfusion and nutrition in vivo; we hypothesized that it may also play a role in stem cell-driven spheroid formation in vitro. Using a model of melanoma in vitro tumorigenesis, laminin-associated networks developed in association with three-dimensional melanoma spheroids. Real-time PCR analysis of laminin subunits showed that spheroids formed from anchorage-independent melanoma cells expressed increased α4 and ß1 laminin chains and α4 laminin expression was confirmed by in situ hybridization. Association of laminin networks with melanoma stem cell-associated nestin and vascular endothelial growth factor receptor-1 also was documented. Moreover, knockdown of nestin gene expression impaired laminin expression and network formation within spheroids. Laminin networks were remarkably similar to those observed in melanoma xenografts in mice and to those seen in patient melanomas. These data indicate that vasculogenic mimicry-like laminin networks, in addition to their genesis in vivo, are integral to the extracellular architecture of melanoma spheroids in vitro, where they may serve as stimulatory scaffolds to support three-dimensional growth.